Physician profile
Jonathan M Doty
NPI 1467412007
$1,400.10
in general payments reported to CMS, 2019-2025
20 companies · $581 in 2025
The $581 reported for 2025 was more than what a typical Otolaryngology provider received nationally (typical 2025 total: $317).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $111 · 2020: $78.18 · 2021: $85.14 · 2023: $151 · 2024: $394 · 2025: $581.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,027 · Education: $99.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,026.86 |
| Education | $99.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Inspire Medical Systems, INC. | $323.00 | 2023-2025 | Inspire |
| Genzyme Corporation | $169.52 | 2024-2025 | |
| Stryker Corporation | $137.50 | 2019-2025 | Clarifix Cryotherapy Device, Scopis Ent |
| Sanofi-Aventis U.S. LLC | $99.00 | 2025 | |
| Optinose US, INC. | $94.84 | 2019-2024 | |
| Regeneron Healthcare Solutions, INC. | $81.76 | 2021-2025 | Dupixent |
| Glaxosmithkline, LLC. | $78.79 | 2023-2025 | Nucala |
| Integra Lifesciences Corporation | $53.71 | 2024 | Inspira Air, Acclarent Aera, Relieva Spinplus Nav |
| Merck Sharp & Dohme LLC | $53.58 | 2025 | Keytruda, Keytruda Qlex |
| Amgen INC. | $45.51 | 2025 | Tezspire |
| Medtronic, INC. | $44.79 | 2023 | Bizact, Propel |
| Alk-Abello, INC | $44.64 | 2021 | |
| Medtronic USA, INC. | $28.65 | 2019 | |
| Paratek Pharmaceuticals, INC. | $26.36 | 2025 | Xhance |
| Organogenesis INC. | $26.11 | 2023 | Puraply |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intersect Ent, INC. | $24.87 | 2021 | |
| Biotissue Holdings INC. | $19.47 | 2025 | |
| Preceptis Medical, INC. | $17.33 | 2025 | |
| Olympus America INC. | $16.71 | 2020 | |
| Karl Storz Endoscopy-America | $13.96 | 2025 | N.A. |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jonathan Doty listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.